Cost-effectiveness of pharmacogenomics in clinical practice: a case study of thiopurine methyltransferase genotyping in acute lymphoblastic leukemia in Europe

Author： van den Akker-van Marle M Elske   Gurwitz David   Detmar Symone B   Enzing Christine M   Hopkins Michael M   Gutierrez de Mesa Emma   Ibarreta Dolores  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.7, Iss.5, 2006-07, pp. : 783-792

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Clinical Pharmacogenomics of Thiopurine S-methyltransferase

By  

Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. : 119-128

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical Utility of Thiopurine S -Methyltransferase Genotyping

By Corominas H.  

American Journal of PharmacoGenomics, Vol. 4, Iss. 1, 2004-01 ,pp. : 1-8

Adis International

Access to resources Recommend Favorite

The thiopurine S-methyltransferase gene locus – implications for clinical pharmacogenomics

By McLeod Howard L   Siva Chokkalingam  

Pharmacogenomics, Vol. 3, Iss. 1, 2002-01 ,pp. : 89-98

Future Medicine

Access to resources Recommend Favorite

Cost–effectiveness analysis in pharmacogenomics

By Payne Katherine   Shabaruddin Fatiha H  

Pharmacogenomics, Vol. 11, Iss. 5, 2010-05 ,pp. : 643-646

Future Medicine

Access to resources Recommend Favorite

Research Highlights: Highlights from the latest articles in acute lymphoblastic leukemia pharmacogenomics

By Stocco Gabriele   Franca Raffaella   Londero Margherita   Decorti Giuliana  

Pharmacogenomics, Vol. 14, Iss. 3, 2013-02 ,pp. : 235-239

Future Medicine

Access to resources Recommend Favorite